Prompt
Are there any cell therapy news sites that focus on comparing headlines across therapies?
Latest observation
Yes — though they’re not always branded specifically as “comparison” sites, there are several news and intelligence sources that let you compare cell therapy headlines across companies, modalities, and indications. The best fit depends on whether you want news aggregation, pipeline tracking, or competitive intelligence.
Good options
1. BioCentury / Endpoint / Fierce Biotech / STAT
- These aren’t comparison tools per se, but they cover multiple cell therapy programs and companies in a way that makes cross-therapy comparison easy.
- Best for: keeping up with major headlines and seeing how one therapy is positioned versus another.
2. Evaluate Vantage / Evaluate / Clarivate / Citeline
- More analytics-oriented.
- Useful if you want to compare therapies by development stage, trial status, market outlook, or commercial potential rather than just headline volume.
3. GlobalData Pharma / Scrip / Pink Sheet
- Often provide broader competitive coverage across cell therapies and adjacent modalities.
- Better if you want structured reporting across multiple therapy classes.
4. SEC filings + press release aggregators
- For headline comparison across therapies, some people use:
- Business Wire / GlobeNewswire / PR Newswire
- Google News
- AlphaSense or FactSet if you have access
- These are good for comparing what companies are saying about their own cell therapies, but they’re less editorial.
5. Pipeline databases with news overlays
- Examples: Citeline, Pharma Intelligence, AdisInsight, EvaluatePharma
- These can be especially helpful if your goal is to compare:
- CAR-T vs TCR-T
- autologous vs allogeneic
- early-stage vs late-stage programs
- specific indications like oncology vs autoimmune disease
If you want “headline comparison” specifically
There are a few approaches:
- News aggregators that let you track keywords like “CAR-T,” “TIL,” “NK cell,” “iPSC,” etc.
- Competitive intelligence platforms that combine pipeline data with news
- Custom dashboards built from RSS feeds, Google News alerts, or APIs
My quick recommendation
If you want something close to a “compare headlines across therapies” experience:
- Free/lightweight: Google News + RSS feeds + keyword alerts
- Best all-around paid: Citeline / Evaluate / AlphaSense
- Best editorial coverage: Fierce Biotech + STAT + BioCentury
If you want, I can also give you:
- a list of sites specifically covering cell therapy only, or
- a comparison table of tools by cost, depth, and how well they compare therapies.
Observation history
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI,
ChatGPT,
Google,
Gemini,
Google AI Mode,
Anthropic,
Claude,
Perplexity,
Grok,
DeepSeek,
Mistral,
Copilot,
Meta AI,
Qwen.
How can brands improve their AEO?
Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.
Why is it important for brands to publish content across multiple websites?
Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.
Want this interpreted for your brand?
Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.